Tag: Symbyax

The combination of olanzapine and fluoxetine is an FDA-approved treatment, marketed under the brand name Symbyax, for specific mental health conditions, including depressive episodes of bipolar I disorder and treatment-resistant depression. However, this powerful combination requires careful medical supervision due to significant potential side effects and drug interactions.

Up to 30% of patients with major depression do not respond to conventional antidepressant treatments. This article details what antidepressants work well with olanzapine as an effective augmentation strategy for treatment-resistant depression and bipolar depression.

Over 634,000 patients were prescribed olanzapine in 2020, making it a commonly used atypical antipsychotic. For those taking this medication, understanding its different brand names and formulations is essential, especially when asking, 'Is there another name for olanzapine?' This guide will clarify the relationship between the generic and brand versions of this important medication.